RBC Bioscience Corporation (TPEX:6848)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Manufacture and Sales of Reagents and Instruments	219.71M	205.25M	172.47M	173.89M	251.18M
Total	219.71M	205.25M	172.47M	173.89M	251.18M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Taiwan	14.31M	13.83M	14.67M	20.01M	17.32M
Europe	146.34M	140.56M	112.03M	105.15M	148.20M
Asia	31.69M	23.93M	18.07M	19.66M	41.86M
Africa	14.51M	13.99M	16.56M	10.27M	17.89M
America	12.84M	12.83M	11.08M	18.79M	25.90M
Other Countries	21.00K	105.00K	65.00K	-	-
Australia	-	-	-	6.00K	20.00K
Total	219.71M	205.25M	172.47M	173.89M	251.18M

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error